Boehringer Ingelheim Competitors and Similar CompaniesClear all
Boehringer Ingelheim's competitors and similar companies include Pfizer and GSK.
 Boehringer Ingelheim Boehringer Ingelheim International is a pharmaceutical company specializing in animal health, human pharma, and biopharmaceutical contract manufacturing. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | |
Founding Date | Founding Date 1958 | Founding Date 1849 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Ingelheim am Rhein, DE HQ Ouled Fayet, DZ Munro, AR Macquarie Park, AU Wien, AT Minsk, BY Bruxelles, BE see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more |
Employees | Employees 1,2338% increase | Employees 81,0008% decrease | Employees 68,629 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) 862.5 m |
Financial | |||
Revenue (est.) | Revenue (est.) €12.7b (FY, 2023) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) |
Cost of goods | Cost of goods €4b (FY, 2023) | Cost of goods $16.1b (FY, 2025) | Cost of goods £5.6b (FY, 2025) |
Gross profit | Gross profit €8.7b (FY, 2023) | Gross profit $46.5b (FY, 2025) | Gross profit £28.5b (FY, 2025) |
Net income | Net income €5.8b (FY, 2023) | Net income $7.8b (FY, 2025) | Net income £6.3b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 200 (FY, 2024) | Countries 92 (FY, 2021) |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products 16 (FY, 2021) |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products 6 (FY, 2021) |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products 11 (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company